Republic of India Compliance

Republic of India Regulatory & Compliance Statement

Public regulatory and compliance statement for Republic of India DPDP, CDSCO/medical-device, telemedicine, healthcare advertising, ISO/BIS readiness, securities, and institutional pilot considerations.

Last updated: 27 June 2026

DPDP Data Fiduciary Position

For India data principals submitting personal data through the website, Provenant AI Labs Pte. Ltd. acts as the data fiduciary unless a separate written agreement states otherwise. Personal data is processed for notified purposes such as responding to enquiries, evaluating pilot discussions, managing commercial communications, security, compliance, and recordkeeping. India-facing practices should be reviewed against the Digital Personal Data Protection Act, 2023 and applicable Digital Personal Data Protection Rules as they come into force.

CDSCO Medical-Device Position

Public product and case-study pages are not advertisements for diagnosis, cure, mitigation, treatment, monitoring, or prevention of disease in India. Provenant products are not represented as CDSCO-registered or approved medical devices, diagnostic systems, treatment systems, monitoring systems, or patient management systems in India. Any India deployment requires classification, licensing, registration, clinical, cybersecurity, procurement, and institutional review under applicable law, including the Medical Devices Rules, 2017 where relevant.

Telemedicine Position

Provenant AI Labs does not provide medical consultation or telemedicine services to patients. Any India telemedicine service must be provided by appropriately qualified Registered Medical Practitioners and healthcare institutions under applicable National Medical Commission, Ministry of Health and Family Welfare, state medical council, and institutional requirements.

ISO Standards Roadmap

Provenant AI Labs plans to maintain an ISO-aligned readiness roadmap for information security, privacy, quality management, telehealth service planning, laboratory-facing workflows, and regulated product development. Candidate frameworks may include ISO/IEC 27001 for information security management, ISO/IEC 27701 for privacy information management, ISO 9001 for quality management, ISO 13131 for telehealth services quality planning, ISO 13485 if a product is formally taken forward as a medical-device design, manufacture, service, or delivery system, ISO 15189 and ISO 15190 for medical laboratory quality/competence and safety considerations, and ISO/IEC 17025 where testing or calibration laboratory competence is in scope. No ISO certification, accreditation, or conformity assessment is claimed unless expressly published by Provenant AI Labs with the applicable scope, certificate body, certificate number, and validity period.

BIS / ISI Mark Roadmap For India

For India market entry, Provenant AI Labs will assess whether any hardware appliance, peripheral, electrical/electronic component, medical device, or packaged product falls within a Bureau of Indian Standards compulsory certification scheme, Quality Control Order, Scheme I ISI Mark requirement, Scheme II registration requirement, or other applicable conformity assessment route. ISI/BIS marking will not be used, displayed, or implied unless the relevant product, Indian Standard, licence, marking permission, and scope have been confirmed by BIS or another competent authority.

Investor And Securities Notice

This website is not a public offer, private placement invitation, prospectus, placement memorandum, or solicitation under the Companies Act, SEBI regulations, or other Indian securities laws. Any India investor discussion is subject to prior legal review and applicable eligibility requirements.

Reference Frameworks

This country regulatory and compliance statement is for general information only. It is not legal, medical, regulatory, investment, procurement, or clinical advice and does not replace formal review by qualified counsel, clinicians, regulators, or institutional stakeholders.